Shinpoong Pharmaceutical Co Ltd (019175) — Cash Flow Quality Index

Latest as of December 2025: 7.40x

Shinpoong Pharmaceutical Co Ltd (019175) has a Cash Flow Quality Index of 7.40x as of December 2025. Operating cash flow of ₩3.42 Billion exceeds net income of ₩461.37 Million, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Shinpoong Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

7.40x
Operating CF / Net Income

Operating Cash Flow

₩3.42 Billion
KRW

Net Income

₩461.37 Million
KRW

Data as of

Dec 2025
Most recent filing

Shinpoong Pharmaceutical Co Ltd Cash Flow Quality Index (2014–2025)

Historical Cash Flow Quality Index for Shinpoong Pharmaceutical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shinpoong Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Shinpoong Pharmaceutical Co Ltd (2014–2025)

Year-by-year earnings quality comparison for Shinpoong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Shinpoong Pharmaceutical Co Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 1.96x ₩17.25 Billion ₩8.83 Billion ▼ -51.2%
2020 4.01x ₩20.06 Billion ₩5.00 Billion ▲ +10.3%
2019 3.63x ₩19.35 Billion ₩5.32 Billion ▼ -68.2%
2018 11.43x ₩32.05 Billion ₩2.80 Billion ▲ +1.9%
2017 11.21x ₩10.15 Billion ₩904.89 Million ▲ +67.4%
2015 6.70x ₩9.89 Billion ₩1.48 Billion ▲ +46702.3%
2014 -0.01x ₩-48.16 Million ₩3.35 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.